Sanar Yokhana, MD
Orthopaedic Surgery · Detroit, MINPI 1043673809
Payments from drug & device makers
Across 77 payments — averaging $184.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Encore Medical, LP$5K
- Pinnacle, Inc$4K
- Smith+Nephew$2K
- Stryker$1K
- Johnson & Johnson$1K
- Medical Device Business Services, Inc.$258
- plus $636 from 7 others
What the payments were for
- Speaking & faculty fees$1,50011%
- Travel & lodging$6,22244%
- Food & beverage$2,38317%
- Education$4,09729%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Encore Medical, LP | 24 | $5,085 |
| Pinnacle, Inc | 8 | $4,097 |
| Smith+Nephew | 9 | $1,624 |
| Stryker | 11 | $1,269 |
| Johnson & Johnson | 3 | $1,232 |
| Medical Device Business Services, Inc. | 5 | $258 |
| Aroa Biosurgery Incorporated | 1 | $155 |
| Orthalign Inc | 2 | $138 |
| Ferring Pharmaceuticals Inc. | 8 | $130 |
| Zimmer Biomet | 3 | $85 |
| Medacta USA, Inc. | 1 | $59 |
| Linkbio Corp | 1 | $37 |
| Acera Surgical, Inc. | 1 | $31 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DJO SURGICAL$5,618
- REDAPT$1,372
- ATTUNE$1,232
- OR3O Dual Mobility$996
- POLARSTEM$996
- MAKO$796
- DJO Surgical Empowr Knee System$547
- Tandem$230
- TFN-Advance$185
- ORTHOLOC 3DI$167
- Journey II$133
- ORTHALIGN PLUS$111
How this compares
$14,201 in reported general payments places this provider in the 75th percentile of 829 orthopaedic surgery providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium | 203 | $7,895 |
| Celecoxib | 76 | $1,730 |
| Meloxicam | 442 | $1,212 |
| Oxycodone Hcl | 58 | $281 |
| Gabapentin | 39 | $231 |
| Amoxicillin | 43 | $176 |
| Mupirocin | 26 | $137 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 19 | $102 |
| Tramadol Hcl | 37 | $101 |
| Ibuprofen | 11 | $87 |
| Ondansetron Hcl | 28 | $71 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Detroit
- Stephen BartolDetroit$2.6M
- Craig SilvertonDetroit$725K
- Stephanie MuhDetroit$523K
- Rahul VaidyaDetroit$238K
- Thomas LynchDetroit$221K
- Jonathan BramanDetroit$133K
- Asheesh BediAnn Arbor$9.4M
- Jerome WiaterBeverly Hills$5.7M
- Jad KhalilSouthfield$3.7M
- Mark PintoChelsea$3.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.